AFLURIA INFLUENZA VACCINE

Serial Number 98402574
730

Registration Progress

Application Filed
Feb 12, 2024
Under Examination
Nov 26, 2024
Approved for Publication
Oct 15, 2024
Published for Opposition
Oct 15, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Nov 26, 2025 121 days

Trademark Image

AFLURIA INFLUENZA VACCINE

Basic Information

Serial Number
98402574
Filing Date
February 12, 2024
Published for Opposition
October 15, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
730
Status Date
May 16, 2025
Application
Pending
Classes
005

Rights Holder

CSL Limited

99
Address
655 Elizabeth Street
Melbourne VIC3000
AU

Ownership History

CSL Limited

Original Applicant
99
Melbourne AU

CSL Limited

Owner at Publication
99
Melbourne AU

Legal Representation

Attorney
Nancy Sabarra

USPTO Deadlines

Next Deadline
121 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
November 26, 2025
Extension Available
Until November 26, 2025

Application History

14 events
Date Code Type Description Documents
May 17, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 16, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 16, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
May 16, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 26, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 15, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 15, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 25, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 9, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 5, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 22, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 22, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Feb 29, 2024 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Feb 12, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Influenza vaccines for human use

Additional Information

Design Mark
The mark consists of the wording "AFLURIA" above the wording "INFLUENZA VACCINE" with a design of six sets of three quadrilaterals increasing in size as they emanate in a semi-circle formation from the "A" in "AFLURIA".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"INFLUENZA VACCINE"